BlackRock Investment Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$17K Hold
1,354
﹤0.01% 3407
2016
Q3
$25K Hold
1,354
﹤0.01% 3301
2016
Q2
$14K Sell
1,354
-26,235
-95% -$271K ﹤0.01% 3476
2016
Q1
$521K Buy
27,589
+352
+1% +$6.65K ﹤0.01% 2878
2015
Q4
$725K Buy
27,237
+113
+0.4% +$3.01K ﹤0.01% 2804
2015
Q3
$1.24M Sell
27,124
-965
-3% -$44K ﹤0.01% 2441
2015
Q2
$904K Buy
28,089
+5,266
+23% +$169K ﹤0.01% 2840
2015
Q1
$726K Buy
22,823
+81
+0.4% +$2.58K ﹤0.01% 2739
2014
Q4
$860K Sell
22,742
-100
-0.4% -$3.78K ﹤0.01% 2642
2014
Q3
$603K Buy
22,842
+634
+3% +$16.7K ﹤0.01% 2861
2014
Q2
$657K Buy
22,208
+4,780
+27% +$141K ﹤0.01% 2875
2014
Q1
$645K Buy
17,428
+95
+0.5% +$3.52K ﹤0.01% 2793
2013
Q4
$718K Sell
17,333
-213
-1% -$8.82K ﹤0.01% 2725
2013
Q3
$930K Buy
17,546
+1,105
+7% +$58.6K ﹤0.01% 2486
2013
Q2
$878K Buy
+16,441
New +$878K ﹤0.01% 2465